Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence.

Source:http://linkedlifedata.com/resource/pubmed/id/20937741

Download in:

View as

General Info

PMID
20937741